Artia Global Partners LP
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 95% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
49 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Portfolio Trend
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $499,419,986 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | +25,000 | 65,000 | $3,779,750 | |
| RVMD | Revolution Medicines, Inc. | +20,800 | 124,990 | $12,155,277 | |
| BTSG | BrightSpring Health Services, Inc. | +12,200 | 53,800 | $2,292,418 | |
| BLTE | Belite Bio, Inc | +7,000 | 24,989 | $3,984,246 | |
| DRUG | Bright Minds Biosciences Inc. | +5,000 | 38,407 | $2,802,558 | |
| CELC | Celcuity Inc. | +2,676 | 15,576 | $1,777,844 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| VKTX | Viking Therapeutics, Inc. | −538,634 | 180,731 | $5,880,986 | |
| SLNO | Soleno Therapeutics Inc | −515,208 | 68,490 | $2,293,045 | |
| INSM | INSMED Inc | −193,800 | 908,412 | $148,543,530 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | −42,100 | 162,990 | $13,678,120 | |
| ARGX | Argenx SE | −34,960 | 29,739 | $21,716,904 | |
| PROK | Prokidney Corp. | −31,472 | 1,806,939 | $3,234,420 | |
| AVTX | Avalo Therapeutics, Inc. | −12,600 | 28,970 | $432,522 | |
| LLY | ELI LILLY & Co | −12,280 | 38,220 | $35,153,609 | |
| ABVX | Abivax S.A. | −9,900 | 600,747 | $66,893,178 | |
| NUVL | Nuvalent, Inc. | −3,200 | 4,900 | $502,005 | |
| PTGX | Protagonist Therapeutics, Inc | −20 | 22,931 | $2,416,927 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AZN | Astrazeneca PLC | 95,376 | $18,810,054 | |
| MRNA | Moderna, Inc. | 200,000 | $10,160,000 | |
| ALMS | Alumis Inc. | 325,046 | $7,160,763 | |
| MRK | Merck & Co., Inc. | 46,700 | $5,617,543 | |
| TERN | Terns Pharmaceuticals, Inc. | 104,800 | $5,525,056 | |
| JNJ | Johnson & Johnson | 22,600 | $5,524,344 | |
| BIIB | Biogen Inc. | 18,437 | $3,380,055 | |
| EWTX | Edgewise Therapeutics, Inc. | 65,500 | $2,063,250 | |
| CYTK | Cytokinetics Inc | 16,300 | $1,074,333 | |
| ELVN | Enliven Therapeutics, Inc. | 20,900 | $819,280 | |
| APGE | Apogee Therapeutics, Inc. | 5,886 | $495,424 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| QURE | uniQure N.V. | 1,023,539 | $24,493,288 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 17,400 | $6,919,110 | |
| PVLA | Palvella Therapeutics, Inc. | 59,200 | $6,196,464 | |
| OCUL | Ocular Therapeutix, Inc | 226,261 | $2,746,808 | |
| UPB | Upstream Bio, Inc. | 68,653 | $1,863,928 | |
| ANRO | Alto Neuroscience, Inc. | 29,192 | $519,617 | |
| LYRA | Lyra Therapeutics, Inc. | 8,756 | $26,968 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| INSM |
INSMED Inc
PUT
+ SHARES
Healthcare
|
Reduced | 908,412 | $148,543,530 | 29.74% | |
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 600,747 | $66,893,178 | 13.39% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 38,220 | $35,153,609 | 7.04% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Held | 2,013,602 | $24,022,271 | 4.81% | |
| ARGX |
Argenx SE
Healthcare
|
Reduced | 29,739 | $21,716,904 | 4.35% | |
| AZN |
Astrazeneca PLC
Healthcare
|
NEW | 95,376 | $18,810,054 | 3.77% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Held | 503,936 | $16,130,991 | 3.23% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Reduced | 162,990 | $13,678,120 | 2.74% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 124,990 | $12,155,277 | 2.43% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Held | 144,376 | $10,841,193 | 2.17% | |
| MRNA |
Moderna, Inc.
CALL
Healthcare
|
NEW | 200,000 | $10,160,000 | 2.03% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
Held | 767,098 | $9,887,893 | 1.98% | |
| DGX |
Quest Diagnostics Inc
Healthcare
|
Held | 40,817 | $7,999,315 | 1.60% | |
| ALMS |
Alumis Inc.
Healthcare
|
NEW | 325,046 | $7,160,763 | 1.43% | |
| VKTX |
Viking Therapeutics, Inc.
Healthcare
|
Reduced | 180,731 | $5,880,986 | 1.18% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
NEW | 46,700 | $5,617,543 | 1.12% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
NEW | 104,800 | $5,525,056 | 1.11% | |
| JNJ |
Johnson & Johnson
Healthcare
|
NEW | 22,600 | $5,524,344 | 1.11% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
Held | 119,741 | $4,800,416 | 0.96% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Held | 96,285 | $4,733,370 | 0.95% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
Held | 138,508 | $4,333,915 | 0.87% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Held | 17,740 | $4,057,670 | 0.81% | |
| BLTE |
Belite Bio, Inc
Healthcare
|
Added | 24,989 | $3,984,246 | 0.80% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Added | 65,000 | $3,779,750 | 0.76% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Held | 137,800 | $3,733,002 | 0.75% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Held | 129,800 | $3,595,460 | 0.72% | |
| PALI |
Palisade Bio, Inc.
Healthcare
|
Held | 1,992,367 | $3,486,642 | 0.70% | |
| BIIB |
Biogen Inc.
Healthcare
|
NEW | 18,437 | $3,380,055 | 0.68% | |
| PROK |
Prokidney Corp.
Healthcare
|
Reduced | 1,806,939 | $3,234,420 | 0.65% | |
| ABBV |
AbbVie Inc.
Healthcare
|
Held | 14,500 | $3,153,605 | 0.63% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Held | 5,000 | $2,964,900 | 0.59% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Added | 38,407 | $2,802,558 | 0.56% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Reduced | 22,931 | $2,416,927 | 0.48% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Reduced | 68,490 | $2,293,045 | 0.46% | |
| BTSG |
BrightSpring Health Services, Inc.
Healthcare
|
Added | 53,800 | $2,292,418 | 0.46% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
Held | 70,700 | $2,100,497 | 0.42% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
NEW | 65,500 | $2,063,250 | 0.41% | |
| CELC |
Celcuity Inc.
Healthcare
|
Added | 15,576 | $1,777,844 | 0.36% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Held | 20,400 | $1,514,904 | 0.30% | |
| KNSA |
Kiniksa Pharmaceuticals International, plc
Healthcare
|
Held | 29,200 | $1,405,980 | 0.28% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
NEW | 16,300 | $1,074,333 | 0.22% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
NEW | 20,900 | $819,280 | 0.16% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Held | 2,500 | $805,475 | 0.16% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
Held | 42,080 | $672,859 | 0.13% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
Held | 17,019 | $648,764 | 0.13% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Reduced | 4,900 | $502,005 | 0.10% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
NEW | 5,886 | $495,424 | 0.10% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
Reduced | 28,970 | $432,522 | 0.09% | |
| PEPG |
PepGen Inc.
Healthcare
|
Held | 205,324 | $363,423 | 0.07% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.